Annual Cash & Cash Equivalents
$1.10 B
+$130.00 M+13.46%
December 1, 2024
Summary
- As of February 20, 2025, CL annual cash & cash equivalents is $1.10 billion, with the most recent change of +$130.00 million (+13.46%) on December 1, 2024.
- During the last 3 years, CL annual cash & cash equivalents has risen by +$264.00 million (+31.73%).
- CL annual cash & cash equivalents is now -28.60% below its all-time high of $1.53 billion, reached on December 31, 2017.
Performance
CL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.10 B
-$138.00 M-11.18%
December 1, 2024
Summary
- As of February 20, 2025, CL quarterly cash and cash equivalents is $1.10 billion, with the most recent change of -$138.00 million (-11.18%) on December 1, 2024.
- Over the past year, CL quarterly cash and cash equivalents has increased by +$130.00 million (+13.46%).
- CL quarterly cash and cash equivalents is now -38.94% below its all-time high of $1.79 billion, reached on March 31, 2014.
Performance
CL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.5% | +13.5% |
| 3 y3 years | +31.7% | +26.4% |
| 5 y5 years | +24.1% | +26.4% |
CL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.4% | -11.2% | +41.4% |
| 5 y | 5-year | at high | +41.4% | -11.2% | +41.4% |
| alltime | all time | -28.6% | +1819.4% | -38.9% | +1819.4% |
Colgate-Palmolive Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.10 B(+13.5%) | $1.10 B(-11.2%) |
| Sep 2024 | - | $1.23 B(+11.2%) |
| Jun 2024 | - | $1.11 B(+2.9%) |
| Mar 2024 | - | $1.08 B(+11.7%) |
| Dec 2023 | $966.00 M(+24.6%) | $966.00 M(+1.6%) |
| Sep 2023 | - | $951.00 M(+16.1%) |
| Jun 2023 | - | $819.00 M(-5.5%) |
| Mar 2023 | - | $867.00 M(+11.9%) |
| Dec 2022 | $775.00 M(-6.9%) | $775.00 M(-17.4%) |
| Sep 2022 | - | $938.00 M(+9.3%) |
| Jun 2022 | - | $858.00 M(-2.2%) |
| Mar 2022 | - | $877.00 M(+5.4%) |
| Dec 2021 | $832.00 M(-6.3%) | $832.00 M(-13.2%) |
| Sep 2021 | - | $958.00 M(+2.2%) |
| Jun 2021 | - | $937.00 M(-5.8%) |
| Mar 2021 | - | $995.00 M(+12.0%) |
| Dec 2020 | $888.00 M(+0.6%) | $888.00 M(-10.2%) |
| Sep 2020 | - | $989.00 M(-0.8%) |
| Jun 2020 | - | $997.00 M(+16.7%) |
| Mar 2020 | - | $854.00 M(-3.3%) |
| Dec 2019 | $883.00 M(+21.6%) | $883.00 M(-6.9%) |
| Sep 2019 | - | $948.00 M(+9.8%) |
| Jun 2019 | - | $863.00 M(+2.4%) |
| Mar 2019 | - | $843.00 M(+16.1%) |
| Dec 2018 | $726.00 M(-52.7%) | $726.00 M(-13.7%) |
| Sep 2018 | - | $841.00 M(+1.0%) |
| Jun 2018 | - | $833.00 M(-2.1%) |
| Mar 2018 | - | $851.00 M(-44.6%) |
| Dec 2017 | $1.53 B(+16.7%) | $1.53 B(+11.2%) |
| Sep 2017 | - | $1.38 B(+11.2%) |
| Jun 2017 | - | $1.24 B(-7.9%) |
| Mar 2017 | - | $1.35 B(+2.4%) |
| Dec 2016 | $1.31 B(+35.6%) | $1.31 B(+1.3%) |
| Sep 2016 | - | $1.30 B(+19.6%) |
| Jun 2016 | - | $1.08 B(+7.0%) |
| Mar 2016 | - | $1.01 B(+4.5%) |
| Dec 2015 | $970.00 M(-10.9%) | $970.00 M(-32.9%) |
| Sep 2015 | - | $1.45 B(+36.4%) |
| Jun 2015 | - | $1.06 B(+23.3%) |
| Mar 2015 | - | $859.00 M(-21.1%) |
| Dec 2014 | $1.09 B(+13.2%) | $1.09 B(-19.6%) |
| Sep 2014 | - | $1.35 B(+16.7%) |
| Jun 2014 | - | $1.16 B(-35.3%) |
| Mar 2014 | - | $1.79 B(+86.6%) |
| Dec 2013 | $962.00 M(+8.8%) | $962.00 M(+33.4%) |
| Sep 2013 | - | $721.00 M(-18.4%) |
| Jun 2013 | - | $884.00 M(-5.2%) |
| Mar 2013 | - | $932.00 M(+5.4%) |
| Dec 2012 | $884.00 M(+0.7%) | $884.00 M(-2.8%) |
| Sep 2012 | - | $909.00 M(-8.6%) |
| Jun 2012 | - | $995.00 M(-4.7%) |
| Mar 2012 | - | $1.04 B(+18.9%) |
| Dec 2011 | $878.00 M(+79.2%) | $878.00 M(-7.1%) |
| Sep 2011 | - | $945.00 M(+27.9%) |
| Jun 2011 | - | $739.00 M(+7.7%) |
| Mar 2011 | - | $686.00 M(+40.0%) |
| Dec 2010 | $490.00 M(-18.3%) | $490.00 M(-12.7%) |
| Mar 2010 | - | $561.00 M(-6.5%) |
| Dec 2009 | $600.00 M(+8.1%) | $600.00 M(-29.2%) |
| Sep 2009 | - | $847.00 M(-5.5%) |
| Jun 2009 | - | $896.00 M(+27.6%) |
| Mar 2009 | - | $702.20 M(+26.5%) |
| Dec 2008 | $555.00 M(+29.5%) | $555.00 M(-12.6%) |
| Sep 2008 | - | $634.70 M(+1.9%) |
| Jun 2008 | - | $622.80 M(-3.0%) |
| Mar 2008 | - | $642.10 M(+49.8%) |
| Dec 2007 | $428.70 M(-12.4%) | $428.70 M(-31.8%) |
| Sep 2007 | - | $628.40 M(+14.9%) |
| Jun 2007 | - | $546.90 M(+15.3%) |
| Mar 2007 | - | $474.40 M(-3.1%) |
| Dec 2006 | $489.50 M | $489.50 M(-2.7%) |
| Sep 2006 | - | $502.90 M(+16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $430.40 M(+12.4%) |
| Mar 2006 | - | $382.80 M(+12.4%) |
| Dec 2005 | $340.70 M(+6.6%) | $340.70 M(-9.5%) |
| Sep 2005 | - | $376.30 M(-4.0%) |
| Jun 2005 | - | $392.10 M(-5.3%) |
| Mar 2005 | - | $413.90 M(+29.5%) |
| Dec 2004 | $319.60 M(+20.5%) | $319.60 M(-13.8%) |
| Sep 2004 | - | $370.60 M(-11.2%) |
| Jun 2004 | - | $417.30 M(+53.7%) |
| Mar 2004 | - | $271.50 M(+2.3%) |
| Dec 2003 | $265.30 M(+58.0%) | $265.30 M(+3.6%) |
| Sep 2003 | - | $256.10 M(+16.8%) |
| Jun 2003 | - | $219.20 M(+6.5%) |
| Mar 2003 | - | $205.80 M(+22.6%) |
| Dec 2002 | $167.90 M(-2.8%) | $167.90 M(-16.3%) |
| Sep 2002 | - | $200.70 M(-18.9%) |
| Jun 2002 | - | $247.40 M(+33.9%) |
| Mar 2002 | - | $184.80 M(+7.0%) |
| Dec 2001 | $172.70 M(-16.4%) | $172.70 M(-40.4%) |
| Sep 2001 | - | $289.60 M(+15.3%) |
| Jun 2001 | - | $251.10 M(+10.2%) |
| Mar 2001 | - | $227.90 M(+10.3%) |
| Dec 2000 | $206.60 M(+3.5%) | $206.60 M(-2.0%) |
| Sep 2000 | - | $210.90 M(-5.9%) |
| Jun 2000 | - | $224.20 M(+8.6%) |
| Mar 2000 | - | $206.40 M(+3.4%) |
| Dec 1999 | $199.60 M(+9.9%) | $199.60 M(-24.0%) |
| Sep 1999 | - | $262.50 M(+32.5%) |
| Jun 1999 | - | $198.10 M(+4.8%) |
| Mar 1999 | - | $189.00 M(+4.0%) |
| Dec 1998 | $181.70 M(-0.8%) | $181.70 M(-13.5%) |
| Sep 1998 | - | $210.00 M(+19.3%) |
| Jun 1998 | - | $176.10 M(-0.1%) |
| Mar 1998 | - | $176.20 M(-3.8%) |
| Dec 1997 | $183.10 M(-26.2%) | $183.10 M(-19.5%) |
| Sep 1997 | - | $227.40 M(-2.9%) |
| Jun 1997 | - | $234.30 M(+40.0%) |
| Mar 1997 | - | $167.30 M(-32.6%) |
| Dec 1996 | $248.20 M(+18.9%) | $248.20 M(+11.5%) |
| Sep 1996 | - | $222.70 M(+17.3%) |
| Jun 1996 | - | $189.80 M(-8.3%) |
| Mar 1996 | - | $206.90 M(-0.9%) |
| Dec 1995 | $208.80 M(+22.9%) | $208.80 M(-6.8%) |
| Sep 1995 | - | $224.00 M(+35.4%) |
| Jun 1995 | - | $165.40 M(-3.6%) |
| Mar 1995 | - | $171.50 M(+0.9%) |
| Dec 1994 | $169.90 M(+17.9%) | $169.90 M(-6.1%) |
| Sep 1994 | - | $180.90 M(+18.6%) |
| Jun 1994 | - | $152.50 M(+3.1%) |
| Mar 1994 | - | $147.90 M(+2.6%) |
| Dec 1993 | $144.10 M(+22.2%) | $144.10 M(-15.4%) |
| Sep 1993 | - | $170.30 M(+12.8%) |
| Jun 1993 | - | $151.00 M(-14.1%) |
| Mar 1993 | - | $175.70 M(+49.0%) |
| Dec 1992 | $117.90 M(-30.0%) | $117.90 M(-30.9%) |
| Sep 1992 | - | $170.50 M(+0.2%) |
| Jun 1992 | - | $170.20 M(-16.0%) |
| Mar 1992 | - | $202.60 M(+20.2%) |
| Dec 1991 | $168.50 M(+1.3%) | $168.50 M(+31.1%) |
| Sep 1991 | - | $128.50 M(+2.4%) |
| Jun 1991 | - | $125.50 M(-5.4%) |
| Mar 1991 | - | $132.70 M(-20.3%) |
| Dec 1990 | $166.40 M(-58.2%) | $166.40 M(+30.6%) |
| Sep 1990 | - | $127.40 M(-30.4%) |
| Jun 1990 | - | $183.10 M(-23.3%) |
| Mar 1990 | - | $238.70 M(-40.0%) |
| Dec 1989 | $397.90 M(+8.9%) | $397.90 M(+86.6%) |
| Sep 1989 | - | $213.20 M(-41.7%) |
| Dec 1988 | $365.50 M(+540.1%) | $365.50 M(+540.1%) |
| Dec 1987 | $57.10 M(-65.4%) | $57.10 M(-65.4%) |
| Dec 1986 | $165.10 M(-36.4%) | $165.10 M(-36.4%) |
| Dec 1985 | $259.50 M(-26.2%) | $259.50 M(-26.2%) |
| Dec 1984 | $351.70 M | $351.70 M |
FAQ
- What is Colgate-Palmolive annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Colgate-Palmolive?
- What is Colgate-Palmolive annual cash & cash equivalents year-on-year change?
- What is Colgate-Palmolive quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Colgate-Palmolive?
- What is Colgate-Palmolive quarterly cash and cash equivalents year-on-year change?
What is Colgate-Palmolive annual cash & cash equivalents?
The current annual cash & cash equivalents of CL is $1.10 B
What is the all time high annual cash & cash equivalents for Colgate-Palmolive?
Colgate-Palmolive all-time high annual cash & cash equivalents is $1.53 B
What is Colgate-Palmolive annual cash & cash equivalents year-on-year change?
Over the past year, CL annual cash & cash equivalents has changed by +$130.00 M (+13.46%)
What is Colgate-Palmolive quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CL is $1.10 B
What is the all time high quarterly cash and cash equivalents for Colgate-Palmolive?
Colgate-Palmolive all-time high quarterly cash and cash equivalents is $1.79 B
What is Colgate-Palmolive quarterly cash and cash equivalents year-on-year change?
Over the past year, CL quarterly cash and cash equivalents has changed by +$130.00 M (+13.46%)